mSEPT9 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

22 results for “mSEPT9”

Trials

View all 17 →

CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

1,031 participants · First posted Sep 4, 2015

mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

400 participants · First posted Jan 16, 2025

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

639 participants · First posted Oct 17, 2017

Drugs

SMET9

News

Hepion Pharmaceuticals In-Licenses Novel ctRNA Biomarker Assay for Early Hepatocellular Carcinoma Detection

Septa Pharmaceuticals Acquires CeeNU (Lomustine) from Bristol Myers Squibb Canada, Strengthening Oncology Portfolio

Regulatory Roundup: Key Approvals and Submissions in Late September 2024

Page 1 of 3